However, emerging data indicate that the Nrf2 defense mechanism also shields tumor cells from chemotherapeutic agents, radiation therapy and anti-cancer drugs and aberrant elevation of Nrf2 causes therapeutic resistance and metastatic invasion of cancer cells [31] (Figure 1B). This evidence concerns the gene NFE2L2 and neoplasm.